13th Annual World Clinical Biomarkers & CDx Summit
05
Sep
-
08
Sep
2023
When
Boston
USA
Where

Welcome to the 13th Annual World Clinical Biomarkers & CDx Summit, the highly anticipated gathering that brings together over 600 senior decision makers in the field of biomarkers and companion diagnostics (CDx). This industry-led meeting aims to accelerate the co-development of clinically validated and affordable drug-CDx combinations, overcoming challenges in commercialization, reimbursement, and regulation. With a focus on oncology and other therapeutic areas like NASH and neuroscience, this summit is dedicated to advancing personalized medicine and bringing it to patients faster.

At the summit, you will have the opportunity to connect with directors, heads, and VPs of Clinical Biomarkers, Translational Medicine, Precision Medicine, and Companion Diagnostics. Additionally, drug and diagnostic developers, regulatory experts, payors, and notified bodies will be in attendance. This exclusive event provides a platform for knowledge sharing and networking, enabling you to propel your pipelines and make a significant impact on patient outcomes.

By participating in the 13th Annual World Clinical Biomarkers & CDx Summit, you will gain insights into the latest advancements and breakthroughs in biomarker research, CDx development, and precision medicine. You will have access to expert-led discussions, case studies, and presentations focused on addressing key challenges in the field. The summit will cover topics such as commercialization strategies, reimbursement models, regulatory considerations, and the integration of biomarkers and CDx into clinical trials.

Whether you are involved in oncology, NASH, neuroscience, or other therapeutic areas, this event provides a unique opportunity to collaborate with industry leaders, exchange ideas, and forge partnerships. Together, we can overcome barriers and accelerate the delivery of personalized medicine to patients worldwide.

Join us at the 13th Annual World Clinical Biomarkers & CDx Summit and be a part of the global effort to revolutionize healthcare through the power of biomarkers and companion diagnostics. Together, we can transform patient care and improve outcomes for countless individuals.

Similar Events

You May Like

Event

Hanson Wade

0/5
(0)

Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.

05 - 08 Sep 2023
In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

Chief Scientific Officer
Senior Director Regulatory Affairs
Chief Diversity Officer
Director, Pharmacodiagnostic Sciences, Precision Medicine
Senior Vice President, Head of Clinical Development
Senior Principal Scientist, Clinical Biomarker Lead, Translational Medicine
Director, L&D Strategy Lead, Enabling Functions
Chief Marketing Officer
Molecular Diagnostics
Founder and CEO
Deputy Head Diagnostics
Associate Director, RA Device and Combination Products

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Bio-techne

Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tiss

Mission Bio

Mission Bio is a company of passionate people dedicated to solving complex biological problems with precision engineering, innovative biochemistry, and supported bioinformatics.

Almac Group

A unique culture delivering exceptional solutions:
Almac is a financially secure, privately owned organisation with over 6,000 employees located within the US, Europe and Asia. 600+ companies worldwide, including all the market leaders, use ou

Agilent Technologies

Analytical scientists and clinical researchers worldwide rely on Agilent to help fulfill their most complex laboratory demands.

Illumina

At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago.

Roche

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives.

Personalis Inc.

Personalis?is a leader in advanced cancer genomics for enabling the next generation of precision cancer therapies and diagnostics.

ANGLE plc

About ANGLE plc is a specialized medical diagnostics company with products in the cancer diagnostics and fetal health markets. ANGLE plc’s lead product, the Parsortix cell separation system, captures very rare cells from blood.

Tempus Labs, Inc.

Tempus is making precision medicine a reality by applying AI in healthcare, deriving insights from our expansive library of clinical data and molecular data.

Leica Biosystems

Leica Biosystems is a cancer diagnostics company and a global leader in workflow solutions, offering the most comprehensive portfolio from biopsy to diagnosis.

Guardant Health

Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics.

Natera

Natera is a global leader in providing DNA testing across multiple clinical areas including women's health, organ health, and oncology.

Genomenon, Inc

Genomenon is a genomic health IT company that keeps pace with the constant advancements made in genomics and connects that research to patient DNA to help diagnose and treat patients with rare genetic diseases and cancer.

Foundation Medicine

Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer.

Caris Life Sciences

Caris Life Sciences® (Caris) is a molecular science company developing and delivering technologies to revolutionize healthcare.

Lunit

"Lunit, abbreviated from “learning unit,” is a Medical AI software company devoted to developing advanced medical image analytics and novel imaging biomarkers via cutting-edge deep learning technology.

NeoGenomics Laboratories

"NeoGenomics Laboratories is a leading cancer diagnostic reference laboratory that has provided high-quality cancer testing and partnership programs to pathologists and oncologists for over 10 years.

Randox

"Randox is dedicated to improving health worldwide. Established in 1982, Randox is an international health diagnostics company with sales and distribution in 145 countries.

Panakeia

Panakeia offers an AI platform to enable simplified, rapid diagnostics to inform the precision treatment of cancer

Genialis

Advance your drug program from the lab through the clinic with Genialis.

Digital Science

Digital Science is a technology company working to make research more efficient. We invest in, nurture and support innovative businesses and technologies that make all parts of the research process more open and effective.

Organizer

Get emails from us

Thank you
Oops! Something went wrong